| Financial Year |
March 31 2023 |
| Monetary Funds |
6,034,509,205.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,345,732,755.55 |
| Advances to Suppliers |
3,124,130,625.75 |
| Other Receivables |
229,576,443.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,925,660,110.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
483,323,586.33 |
| Total Current Assets |
16,142,932,727.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
200,822,612.81 |
| Investment Properties |
133,720,933.13 |
| Fixed Assetes |
94,023,362.06 |
| Under-construction Projects |
1,460,306,163.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,199,742,502.30 |
| R&D expenses |
-- |
| Goodwill |
907,869,438.06 |
| Long-Term Deferred and Prepaid Expenses |
7,788,180.11 |
| Deferred Income Tax Assets |
44,935,088.49 |
| Other Non-Current Assets |
1,000,000.00 |
| Sub-Total of Non-Current Assets |
5,628,666,730.42 |
| Total Assets |
21,771,599,457.74 |
| Short-Term Loans |
10,035,700,833.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,222,951,099.70 |
| Accounts Payable |
674,443,495.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,980,089.88 |
| Taxes Payable |
54,304,751.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
199,018,661.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,334,432.28 |
| Other Current Liabilities |
41,413,876.34 |
| Sub-Total of Current Liabilities |
16,712,708,679.63 |
| Long-term Loans |
1,045,605,155.27 |
| Bonds Payable |
1,295,014,400.61 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,111,452.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,372,645,649.58 |
| Total Liabilities |
19,085,354,329.21 |
| Paid-In Capital(Or Share Stock) |
1,025,100,438.00 |
| Capital Surplus |
344,951,462.63 |
| Surplus Reserve |
151,754,262.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,145,760,455.29 |
| Minority Stockholder's Interest |
45,766,807.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,640,478,320.88 |
| Owner's Equity（Stockholder's Equity） |
2,686,245,128.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,771,599,457.74 |
